Axillary surgery de-escalation for breast cancer in the era of precision medicine.
作者信息
Du Xueying, Sun Xiao, Liu Yanbing, Zhang Zhaopeng, Wang Yongsheng, Bi Zhao
机构信息
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
出版信息
Cancer Biol Med. 2025 Sep 4;22(8):871-3. doi: 10.20892/j.issn.2095-3941.2025.0255.
Abstract
摘要
相似文献
1
Axillary surgery de-escalation for breast cancer in the era of precision medicine.精准医学时代乳腺癌腋窝手术的降阶梯治疗
Cancer Biol Med. 2025 Sep 4;22(8):871-3. doi: 10.20892/j.issn.2095-3941.2025.0255.
2
[De-escalation in axillary breast cancer surgery: Real-life applications].
Bull Cancer. 2025 Jul-Aug;112(7-8):798-811. doi: 10.1016/j.bulcan.2025.06.006. Epub 2025 Jul 15.
3
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.乳腺癌新辅助化疗后腋窝手术降阶梯治疗的肿瘤学结局：I-SPY2临床试验中1500余例患者的结果
Ann Surg Oncol. 2025 May;32(5):3278-3291. doi: 10.1245/s10434-025-16973-y. Epub 2025 Feb 13.
4
A qualitative study exploring the views of global healthcare professionals towards de-escalation of axillary surgery in early breast cancer.一项定性研究，探讨全球医疗保健专业人员对早期乳腺癌腋窝手术降阶梯治疗的看法。
Eur J Surg Oncol. 2025 Aug;51(8):110079. doi: 10.1016/j.ejso.2025.110079. Epub 2025 Apr 17.
5
Different strategies in de-escalation of axillary surgery in node-positive breast cancer following neoadjuvant treatment: a systematic review and meta-analysis of long-term outcomes.新辅助治疗后腋窝淋巴结阳性乳腺癌腋窝手术降阶梯治疗的不同策略：长期结局的系统评价和荟萃分析
Breast Cancer. 2025 Apr 5. doi: 10.1007/s12282-025-01692-9.
6
Bridging Global Disparities in Breast Cancer Care: External Validation Study of the MD Anderson "Nomogram To Predict Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy" and Its Financial Implications of Axillary De-escalation in a Resource Limited Setting.弥合乳腺癌护理中的全球差距：MD安德森癌症中心“新辅助化疗后预测前哨淋巴结转移的列线图”的外部验证研究及其在资源有限环境下腋窝降级治疗的财务影响
Inquiry. 2025 Jan-Dec;62:469580251366150. doi: 10.1177/00469580251366150. Epub 2025 Aug 21.
7
Omission of axillary lymph node dissection in patients with breast cancer with axillary pathological complete response confirmed by stained region lymph node biopsy after neoadjuvant systemic therapy (SrLNB study): study protocol for a single-arm, single-centre, phase-II trial.新辅助全身治疗后经染色区域淋巴结活检证实腋窝病理完全缓解的乳腺癌患者省略腋窝淋巴结清扫术（SrLNB研究）：一项单臂、单中心、II期试验的研究方案
BMJ Open. 2025 Mar 31;15(3):e092563. doi: 10.1136/bmjopen-2024-092563.
8
Axillary surgery in early breast cancer: real-world analysis of the INSEMA-trial at three certified university breast cancer centers in Germany regarding the omission of sentinel lymph node biopsy.早期乳腺癌的腋窝手术：德国三个认证大学乳腺癌中心关于省略前哨淋巴结活检的INSEMA试验的真实世界分析。
Eur J Surg Oncol. 2025 Oct;51(10):110392. doi: 10.1016/j.ejso.2025.110392. Epub 2025 Aug 14.
9
[The research progress on de-escalation and optimization strategies for the treatment of early-stage breast cancer].[早期乳腺癌治疗中降阶梯与优化策略的研究进展]
Zhonghua Wai Ke Za Zhi. 2025 Aug 1;63(8):682-689. doi: 10.3760/cma.j.cn112139-20241012-00459.
10
Trends in the rate of axillary clearance following the publication of the ACOSOG Z0011 trial: A systematic review.美国外科医师学会肿瘤学组（ACOSOG）Z0011试验发表后腋窝清扫率的趋势：一项系统评价
Eur J Surg Oncol. 2025 Aug;51(8):110023. doi: 10.1016/j.ejso.2025.110023. Epub 2025 Apr 12.
本文引用的文献
1
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.乳腺癌腋窝手术——INSEMA试验的初步结果
N Engl J Med. 2025 Mar 13;392(11):1051-1064. doi: 10.1056/NEJMoa2412063. Epub 2024 Dec 12.
2
Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024.中国临床肿瘤学会（CSCO）乳腺癌诊疗指南2024
Transl Breast Cancer Res. 2024 Jul 25;5:18. doi: 10.21037/tbcr-24-31. eCollection 2024.
3
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.《NCCN 肿瘤学临床实践指南：乳腺癌》第 3.2024 版。
J Natl Compr Canc Netw. 2024 Jul;22(5):331-357. doi: 10.6004/jnccn.2024.0035.
4
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.前哨淋巴结活检与阴性超声腋窝淋巴结结果的小乳腺癌患者不进行腋窝手术的比较：SOUND 随机临床试验。
JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759.
5
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.保乳手术后 Luminal A 型乳腺癌中省略放疗。
N Engl J Med. 2023 Aug 17;389(7):612-619. doi: 10.1056/NEJMoa2302344.
6
Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.早期乳腺癌腋窝管理：安大略省健康（安大略省癌症护理）和 ASCO 指南。
J Clin Oncol. 2021 Sep 20;39(27):3056-3082. doi: 10.1200/JCO.21.00934. Epub 2021 Jul 19.
7
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.为早期乳腺癌女性定制局部和全身治疗方案：《2021年圣加仑早期乳腺癌治疗国际共识指南》
Ann Oncol. 2021 Oct;32(10):1216-1235. doi: 10.1016/j.annonc.2021.06.023. Epub 2021 Jul 6.
8
Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.ERBB2 阳性或三阴性乳腺癌患者低淋巴结阳性率与新辅助化疗后乳腺病理完全缓解的相关性。
JAMA Surg. 2018 Dec 1;153(12):1120-1126. doi: 10.1001/jamasurg.2018.2696.
Zotero 插件